Similar Papers

Paper Title
Journal
Date
Author
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
...
BMJ (Clinical research ed.) | VOL. 378
, et. al. ...
20 Jul 2022
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study
Niklas Worm Andersson ... Anders Hviid
BMJ | VOL. 382
Niklas Worm Andersson, et. al.Niklas Worm Andersson ... Anders Hviid
25 Jul 2023
Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch community cohort.
Vincent Grigori Nguyen ... Madhumita Shrotri
International Journal of Epidemiology | VOL. 52
Vincent Grigori Nguyen, et. al.Vincent Grigori Nguyen ... Madhumita Shrotri
19 Jan 2023
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses
Niklas Worm Andersson ... Anders Hviid
BMJ | VOL. 382
Niklas Worm Andersson, et. al.Niklas Worm Andersson ... Anders Hviid
24 Jul 2023
View more papers

More From: BMJ (Clinical research ed.)

Paper Title
Journal
Date
Author
Would pandemic responses be better directed from central government?
Robert Dingwall
BMJ (Clinical research ed.) | VOL. 388
Robert DingwallRobert Dingwall
05 Feb 2025
Sixty seconds on . . . NHS leaders.
Gareth Iacobucci
BMJ (Clinical research ed.) | VOL. 388
Gareth IacobucciGareth Iacobucci
31 Jan 2025
Obesity: Government accused of kicking problem "into the long grass" despite growing crisis.
Elisabeth Mahase
BMJ (Clinical research ed.) | VOL. 388
Elisabeth MahaseElisabeth Mahase
31 Jan 2025
NICE approves gene editing therapy for patients with severe sickle cell disease.
Carla Delgado
BMJ (Clinical research ed.) | VOL. 388
Carla DelgadoCarla Delgado
31 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.